ONCOBIOPHARM LIMITED

Active Edinburgh

Research and experimental development on biotechnology

5 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
O

ONCOBIOPHARM LIMITED

Research and experimental development on biotechnology

Founded 29 Jul 2005 Active Edinburgh, Scotland 5 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

NUCANA BIOPHARMACEUTICALS LIMITED 2 Nov 2006 — 2 Jul 2008
NUCANA LIMITED 14 Oct 2005 — 2 Nov 2006
DUNWILCO (1277) LIMITED 29 Jul 2005 — 14 Oct 2005
Accounts Submitted 23 Jun 2025 Next due 30 Jun 2026 1 month remaining
Confirmation Submitted 11 Aug 2025 Next due 12 Aug 2026 3 months remaining
Net assets £261K £40K 2024 year on year
Total assets £323K £21K 2024 year on year
Total Liabilities £62K £19K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

1 Lochrin Square 92-98 Fountainbridge Edinburgh EH3 9QA Scotland

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for ONCOBIOPHARM LIMITED (SC288225), an active life sciences and medical technology company based in Edinburgh, Scotland. Incorporated 29 Jul 2005. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£4.45k

Decreased by £28.75k (-87%)

Net Assets

£261.10k

Decreased by £40.28k (-13%)

Total Liabilities

£62.34k

Increased by £18.95k (+44%)

Turnover

N/A

Employees

5

Decreased by 2 (-29%)

Debt Ratio

19%

Increased by 6 (+46%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

9 Allotments 18,314,052 Shares £780k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
31 Oct 2022153,373£71k£0.463
5 Apr 2022485,961£225k£0.463
16 Jan 2017161,988£75k£0.463
13 Dec 2016215,982£100k£0.463
3 Jun 2016269,978£125k£0.463

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (38)

Christopher Barry Wood
48.5%
Scottish Enterprise Glasgow
9.6%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Christopher Barry Wood

British

Active
Notified 6 Apr 2016
Residence United Kingdom
DOB December 1945
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Group Structure

Group Structure

ONCOBIOPHARM LIMITED Current Company
ATEN THERAPEUTICS LTD united kingdom

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
11 Aug 2025Confirmation StatementConfirmation statement made on 29 Jul 2025 with no updates
23 Jun 2025AccountsAnnual accounts made up to 30 Sept 2024
9 Aug 2024Confirmation StatementConfirmation statement made on 29 Jul 2024 with no updates
1 Aug 2024OfficersChange to director Mr Wilfred Sydney Hanna on 22 Jul 2024
25 Jun 2024AccountsAnnual accounts made up to 30 Sept 2023
11 Aug 2025 Confirmation Statement

Confirmation statement made on 29 Jul 2025 with no updates

23 Jun 2025 Accounts

Annual accounts made up to 30 Sept 2024

9 Aug 2024 Confirmation Statement

Confirmation statement made on 29 Jul 2024 with no updates

1 Aug 2024 Officers

Change to director Mr Wilfred Sydney Hanna on 22 Jul 2024

25 Jun 2024 Accounts

Annual accounts made up to 30 Sept 2023

Recent Activity

Latest Activity

Confirmation statement made on 29 Jul 2025 with no updates

8 months ago on 11 Aug 2025

Annual accounts made up to 30 Sept 2024

10 months ago on 23 Jun 2025

Confirmation statement made on 29 Jul 2024 with no updates

1 years ago on 9 Aug 2024

Change to director Mr Wilfred Sydney Hanna on 22 Jul 2024

1 years ago on 1 Aug 2024

Annual accounts made up to 30 Sept 2023

1 years ago on 25 Jun 2024